Omega 3 Fatty Acids: Novel Neurotherapeutic Targets for Cognitive Dysfunction in Mood Disorders and Schizophrenia? - sprookjes - yvandenbroek - TriplyDB

Omega 3 Fatty Acids: Novel Neurotherapeutic Targets for Cognitive Dysfunction in Mood Disorders and Schizophrenia?

Omega 3 Fatty Acids: Novel Neurotherapeutic Targets for Cognitive Dysfunction in Mood Disorders and Schizophrenia?

http://www.wikidata.org/entity/Q26782982

about

The novel lipid mediator PD1n-3 DPA: An overview of the structural elucidation, synthesis, biosynthesis and bioactions.

P2860

Q39365490-832B6581-2A8E-4902-A746-3B4298ECDC9C

P2860

Omega 3 Fatty Acids: Novel Neurotherapeutic Targets for Cognitive Dysfunction in Mood Disorders and Schizophrenia?

http://www.wikidata.org/entity/Q26782982

description

2015 nî lūn-bûn

@nan

2015 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2015 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

name

Omega 3 Fatty Acids: Novel Neu ...... d Disorders and Schizophrenia?

@ast

Omega 3 Fatty Acids: Novel Neu ...... d Disorders and Schizophrenia?

@en

Omega 3 Fatty Acids: Novel Neu ...... d Disorders and Schizophrenia?

@nl

type

label

Omega 3 Fatty Acids: Novel Neu ...... d Disorders and Schizophrenia?

@ast

Omega 3 Fatty Acids: Novel Neu ...... d Disorders and Schizophrenia?

@en

Omega 3 Fatty Acids: Novel Neu ...... d Disorders and Schizophrenia?

@nl

prefLabel

Omega 3 Fatty Acids: Novel Neu ...... d Disorders and Schizophrenia?

@ast

Omega 3 Fatty Acids: Novel Neu ...... d Disorders and Schizophrenia?

@en

Omega 3 Fatty Acids: Novel Neu ...... d Disorders and Schizophrenia?

@nl

P1433

Q26782982-89573F21-B158-4562-88B5-C0E382954FF9

P1476

Q26782982-CDE907AE-0559-4827-BFA3-F4D5C44D1BAD

P2093

Q26782982-1EC01ABF-CE91-40CF-8DCC-07F2D51FA1C5

Q26782982-3A2A03F2-64E5-418B-A402-7557A6447846

Q26782982-3C6AF7BC-CF68-467B-9797-746CB818AC74

Q26782982-50882803-EC2D-443E-9B51-9BB4729F31CA

Q26782982-566CC404-20C7-4CE0-8D4E-E2B4F4092128

Q26782982-5D087138-E7B5-4C5E-96F9-F1B1D1DB7FF8

Q26782982-681CD52D-B13A-4136-B21A-9F5F375C4A55

Q26782982-6E6C173C-B631-4B4A-96FB-9B090C9F1A49

Q26782982-BA7778AF-BFAA-4786-80D7-F98B321486F5

Q26782982-C93ED8FC-B283-41F9-B381-3C18A23AFE3A

P275

Q26782982-E27B2978-80AB-4828-A697-EBB74DF6B457

P2860

Q26782982-023E10B2-F719-4B37-B5EF-B9100A5525C4

Q26782982-044C4515-9763-4006-B80D-C84E36E21EF2

Q26782982-06A29802-410D-4A48-8920-82A0FB432243

Q26782982-0C4A8F89-D7EF-4706-B3BE-A1D3C1C75B5B

Q26782982-0D41BA33-95C7-4A17-B840-36E99C0AB892

Q26782982-0D48ACBA-9F80-4E80-8589-8AD831AACD1F

Q26782982-0F8B8E6C-8D54-4415-AFB8-8A6ABDA058B8

Q26782982-10B039F3-2ED2-4ED1-B845-46B086BF2DC1

Q26782982-13CB719B-2F28-47AB-89B1-8BF9CDE251A6

Q26782982-13CD4FB6-8AB9-4F7C-978F-C609F47D48FE

P304

Q26782982-9BB6E29D-BAE8-495C-B6B0-073BF02788D9

P31

Q26782982-4BF8FBEB-FF2E-4EAA-B62A-BCCD95DE2EB8

Q26782982-50043110-974B-46B2-BBA3-3695E359881C

P356

Q26782982-1CE9B139-7DE9-4F7C-A315-E6A49EA116DC

P407

Q26782982-96CE166C-0075-4507-9192-BC8C17AE78AE

P433

Q26782982-CB72F510-09C1-40D4-B7EA-7AD6914BCA5E

P478

Q26782982-B82BC339-1FC5-41E6-AF25-BAA4827343AB

P5008

Q26782982-C4069A08-C52B-48AD-8B7E-6490F5A046F1

P577

Q26782982-35698CAA-3EC2-4DAC-8437-4C9FD650868F

P698

Q26782982-52EEE90A-AC33-4A04-AE37-4A52AF4EAC56

P921

Q26782982-6ABB9135-E9F6-4797-AA33-D1E416C10902

Q26782982-6FBFB928-8691-43D6-A8C3-70F0BB45C04A

Q26782982-8223C5F4-F6C9-4A2E-9297-3E8666D0BC90

Q26782982-A93ED6D6-D60F-46F4-BF9A-9EF13DA7F4BE

Q26782982-B501AAD4-0D57-43F1-995D-56E8DB02029F

P932

Q26782982-C7D1AFF7-738C-4AD9-BBA1-BF60C420B9A5

P356

1570159X13666150630173047

P1433

Current Neuropharmacology

P1476

Omega 3 Fatty Acids: Novel Neu ...... d Disorders and Schizophrenia?

@en

P2093

André F Carvalho

http://www.w3.org/2001/XMLSchema#string

Beate Sepanski

http://www.w3.org/2001/XMLSchema#string

Christian Knöchel

http://www.w3.org/2001/XMLSchema#string

David Prvulovic

http://www.w3.org/2001/XMLSchema#string

Florian Grüter

http://www.w3.org/2001/XMLSchema#string

Gilberto S Alves

http://www.w3.org/2001/XMLSchema#string

Martin Voss

http://www.w3.org/2001/XMLSchema#string

Michael Stäblein

http://www.w3.org/2001/XMLSchema#string

Silke Matura

http://www.w3.org/2001/XMLSchema#string

Sofia Wenzler

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution-NonCommercial

P2860

Estimating the inbreeding depression on cognitive behavior: a population based study of child cohort

Omega-3 fatty acids and major depression: a primer for the mental health professional

Meta-Analysis of the Effects of Eicosapentaenoic Acid (EPA) in Clinical Trials in Depression

Omega 3 fatty acid for the prevention of cognitive decline and dementia

Neuroprotectin D1: a docosahexaenoic acid-derived docosatriene protects human retinal pigment epithelial cells from oxidative stress

Unmet needs in the treatment of schizophrenia: new targets to help different symptom domains

N-Acyl amines of docosahexaenoic acid and other n-3 polyunsatured fatty acids - from fishy endocannabinoids to potential leads

Novel docosanoids inhibit brain ischemia-reperfusion-mediated leukocyte infiltration and pro-inflammatory gene expression

Novel docosatrienes and 17S-resolvins generated from docosahexaenoic acid in murine brain, human blood, and glial cells. Autacoids in anti-inflammation

Novel eicosanoid and docosanoid mediators: resolvins, docosatrienes, and neuroprotectins

P304

663-680

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2174/1570159X13666150630173047

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

13

http://www.w3.org/2001/XMLSchema#string

P5008

P577

2015-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26467414

http://www.w3.org/2001/XMLSchema#string

P921

cognitive disorder

P932

4761636

http://www.w3.org/2001/XMLSchema#string